Reader Comments

Post a new comment on this article

Erratum: Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical models

Posted by benclin on 29 Aug 2012 at 21:23 GMT

The FGFR4-KO animals were constructed as reported previously [33] and provided by W. L. McKeehan (University of Texas Southwestern Medical Center, Dallas, TX).
http://plosone.org/article/info:doi/10.1371/journal.pone.0036713#article1.body1.sec4.sec16.p3

Erratum: Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical models
Dorothy M. French, Benjamin C. Lin, Manping Wang, Camellia Adams, Theresa Shek, Kathy Hötzel, Brad Bolon, Ronald Ferrando, Craig Blackmore, Kurt Schroeder, Luis A. Rodriguez, Maria Hristopoulos, Rayna Venook, Avi Ashkenazi, Luc R. Desnoyers
PLoS One. 2012;7(5):e36713. Epub 2012 May 15
In the version of this article originally published, the source of the FGFR4 knockout mice was incorrectly attributed. The mice were obtained from the National Institutes of Health (NIH).

Competing interests declared: The authors have the following competing interest: Dorothy M. French, Benjamin C. Lin, Manping Wang, Camellia Adams, Theresa Shek, Kathy Hötzel, Ronald Ferrando, Craig Blackmore, Kurt Schroeder, Luis A. Rodriguez, Maria Hristopoulos, Rayna Venook, Avi Ashkenazi, and Luc R. Desnoyers were full-time employees of Genentech, Inc. at the time this work was completed. Brad Bolon is a full-time employee of GEMpath, Inc. The affiliations with Genentech, Inc. and GEMpath, Inc. do not alter the authors’ adherence to all PLoS ONE policies on sharing data and materials. A patent is pending for the results described herein.
report a concern respond to this posting